Loading…

An R 5 L τ mutation in a subject with a progressive supranuclear palsy phenotype

MAPT , the gene encoding tau, was screened for mutations in 96 progressive supranuclear palsy subjects. A point mutation ( R 5 L ) was identified in a single progressive supranuclear palsy subject that was not in the other progressive supranuclear palsy subjects or in 96 controls. Functionally, this...

Full description

Saved in:
Bibliographic Details
Published in:Annals of neurology 2002-10, Vol.52 (4), p.511-516
Main Authors: Poorkaj, Parvoneh, Muma, Nancy A., Zhukareva, Victoria, Cochran, Elizabeth J., Shannon, Kathleen M., Hurtig, Howard, Koller, William C., Bird, Thomas D., Trojanowski, John Q., Lee, Virginia M.‐Y., Schellenberg, Gerard D.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MAPT , the gene encoding tau, was screened for mutations in 96 progressive supranuclear palsy subjects. A point mutation ( R 5 L ) was identified in a single progressive supranuclear palsy subject that was not in the other progressive supranuclear palsy subjects or in 96 controls. Functionally, this mutation alters the ability of tau to promote microtubule assembly. Analysis of soluble tau from different brain regions indicates that the mutation does not affect the ratio of tau isoforms synthesized. Aggregated insoluble tau from subcortical regions was predominantly four‐repeat tau with no or one amino terminal insert (0N4R and 1N4R). Insoluble tau from cortical regions also contained 1N3R tau. Thus, the R 5 L mutation causes a progressive supranuclear palsy phenotype, presumably by a gain‐of‐function mechanism.
ISSN:0364-5134
1531-8249
DOI:10.1002/ana.10340